Ledger.Open graph →
SEC Form D · filed December 8, 2017

Obsidian Therapeutics, Inc

Offering
$49.9M
Sold
$32.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

David Neafus · Cambridge, MAExecJason Gardner · Irvine, CADirectorCarolyn Ng · Cambridge, MADirectorMichael Gilman · CAMBRIDGE, MAExec · DirectorKaren Hong · Princeton, NJDirectorPeter Barrett · Fort Washington, PAExec · DirectorDavid Neafus · Cambridge, MAExecJason Gardner · CAMBRIDGE, MADirectorCarolyn Ng · Cambridge, MADirectorMichael Gilman · Belmont, MAExec · DirectorKaren Hong · Cambridge, MADirectorPeter Barrett · Cambridge, MAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗